Home › Funds › Millennium Management › LXEO
Millennium Management position in LXEO
LEXEO THERAPEUTICS INC · Health Care
Latest position (Q2 2026)2.83M sh
Reported value held$13.19M
Portfolio Weight0.01%
First reportedQ4 2023
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 44.10K | $591.82K | New |
| Q1 2024 | 593.72K | $8.73M | Add |
| Q2 2024 | 37.47K | $600.96K | Reduce |
| Q3 2024 | 37.11K | $335.51K | Reduce |
| Q4 2024 | 141.95K | $934.04K | Add |
| Q1 2025 | 1.07M | $3.72M | Add |
| Q2 2025 | 2.84M | $11.40M | Add |
| Q3 2025 | 2.31M | $15.36M | Reduce |
| Q4 2025 | 908.02K | $9.02M | Reduce |
| Q1 2026 | 1.61M | $9.26M | Add |
| Q2 2026 | 2.83M | $13.19M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding LXEO
- Vanguard Group 3.89M sh · $38.67M · Q4 2025
- Janus Henderson Group 4.98M sh · $28.51M · Q1 2026
- BlackRock Inc 5.74M sh · $26.72M · Q2 2026
- Citadel Advisors 3.90M sh · $18.15M · Q2 2026
- Balyasny Asset Management 2.41M sh · $11.23M · Q2 2026
- Goldman Sachs Group 2.15M sh · $10.01M · Q2 2026
- Geode Capital Management 1.75M sh · $8.14M · Q2 2026
- Northern Trust Corp 867.39K sh · $4.04M · Q2 2026
- Bank of America Corp 490.33K sh · $2.28M · Q2 2026
- Morgan Stanley 395.10K sh · $1.84M · Q2 2026
- UBS Group AG 354.04K sh · $1.65M · Q2 2026